Health Condition 1: B079- Viral wart, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All diagnosed immunocompetent cases (clinically and dermoscopically) of cutaneous warts (aged 5-70 yrs) attending Dermatology OPD in a tertiary care hospital in Mumbai.
Exclusion criteria
Exclusion criteria: Patients with keloidal tendencies. (2) Patients with prior allergic response to MMR or vitamin D3. (3)Patients with autoimmune conditions. (4) Patients with infected warts (5) Patients with genital warts. (6) Pregnant /lactating females. (7) Known case of HIV/HBsAg/HCV (8)Immunosuppressed patients. (9) Consent Denial, uncooperative patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of resolution of injected warts.Timepoint: Resolution of warts at weeks 2, 4, 6,24 | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare effect of intralesional Vitamin D3 vs MMR vaccine on the resolution of distant warts, other than injected wartsTimepoint: weeks 2,4,6,24 | — |
Countries
India
Contacts
INHS Asvini